Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Short-Term Debt issuances (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Short-Term Debt issuances for 3 consecutive years, with -$63.3 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Short-Term Debt issuances fell 24.85% year-over-year to -$63.3 million, compared with a TTM value of -$63.3 million through Dec 2025, down 602.38%, and an annual FY2025 reading of -$63.3 million, down 602.38% over the prior year.
  • Short-Term Debt issuances was -$63.3 million for Q1 2025 at BrightSpring Health Services, down from -$33.8 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $55.8 million in Q2 2024 and bottomed at -$122.4 million in Q4 2023.
  • Average Short-Term Debt issuances over 3 years is -$20.2 million, with a median of -$33.8 million recorded in 2024.
  • The sharpest move saw Short-Term Debt issuances soared 72.37% in 2024, then decreased 24.85% in 2025.
  • Year by year, Short-Term Debt issuances stood at -$122.4 million in 2023, then skyrocketed by 72.37% to -$33.8 million in 2024, then crashed by 87.28% to -$63.3 million in 2025.
  • Business Quant data shows Short-Term Debt issuances for BTSG at -$63.3 million in Q1 2025, -$33.8 million in Q4 2024, and $41.3 million in Q3 2024.